762-24-3-040-2385 -Tucson CMOP ACAMPROSATE -(VA-24-00083915)
ID: 36C77024Q0392Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)
Timeline
    Description

    The Department of Veterans Affairs is seeking offers for the procurement of Acamprosate 333mg EC tablets through solicitation number 36C77024Q0392, aimed at fulfilling its pharmaceutical needs. Vendors are required to submit a comprehensive proposal that includes pricing schedules, valid state licenses, and certifications related to drug compliance, with a focus on maintaining high standards for product quality and adherence to regulatory requirements. This procurement is crucial for ensuring the availability of essential medications for veterans, while also promoting opportunities for small businesses, particularly those owned by women and service-disabled veterans. Interested vendors must submit their bids by September 17, 2024, at 4:00 PM CST, and can contact Sarah Fry at sarah.fry2@va.gov or 913-758-9935 for further information.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for the procurement of Acamprosate Calcium 333mg extended-release tablets. This requirement is specifically for the VA CMOP facility in Tucson, Arizona, under solicitation number 36C77024Q0392, with a response deadline set for September 17, 2024. The procurement is categorized as a small business set-aside, aligning with NAICS code 325412, which pertains to pharmaceutical manufacturing. Interested vendors must submit their package via email, including documents such as the signed SF1449 cover page, an Excel price schedule, and a valid state wholesale distributor license. Additionally, vendors quoting non-domestic products must provide a Buy American Act certificate. Failure to include required documentation will result in non-compliance. Responses should focus on the specified requirement, with all offers due by the established deadline. The contract aims to ensure a timely delivery of the pharmaceutical within 10 days after receipt of order. The document emphasizes compliance with the Drug Supply Chain Security Act and underscores the importance of registration on SAM.gov for all vendors interested in participating.
    The document details a Request for Quote (RFQ) issued by the Tucson Compounded Medication Operations Program (CMOP) with the RFQ number 36C77024Q0392. Vendors interested in providing ACAMPROSATE CA 333MG EC TAB must submit their bids by the closing date of September 17, 2024, at 4:00 PM CST, with delivery anticipated within ten days of the award. Required submissions include a signed SF1449 form, an excel quote spreadsheet, a valid State Wholesale Distributor License, and a Buy American Act certificate for non-domestic quotes. Vendors must ensure that pharmaceutical expiration dates are at least one year from delivery; any exceptions should be noted in the vendor comments. The specific quantity requested is 180 units, with additional information concerning the manufacturer, packaging, and pricing to be included in the submissions. The RFQ emphasizes a small business set-aside and compliance with the Buy American Act, indicating a preference for domestically sourced products. This RFQ reflects the federal government's ongoing efforts to procure essential pharmaceutical supplies while supporting small businesses.
    The solicitation 36C77024Q0392 invites offers for the procurement of Acamprosate 333mg EC tablets primarily aimed at supporting the Department of Veterans Affairs (VA) in its pharmaceutical needs. The offer deadline is September 17, 2024, with a delivery schedule requiring items to be shipped within 10 days after receipt of the purchase order. Suppliers are expected to provide a comprehensive submission package that includes pricing schedules, valid state licenses, and other certifications related to drug origin and compliance with regulations. Key requirements include adherence to labeling standards, ensuring shipments are adequately documented, and compliance with the Drug Supply Chain Security Act. Contractors must maintain strict product quality, including specific provisions for drug recalls and proper drug labeling, supported by barcoding. The contract terms adhere to the Federal Acquisition Regulation (FAR) and specific VA clauses, detailing payment processes, inspection rights, and termination conditions. The document emphasizes the government's commitment to small businesses, providing set aside opportunities for various categories such as women-owned and service-disabled veteran-owned businesses. This procurement showcases the VA’s effort to ensure high standards for pharmaceuticals supplied to its facilities, aligning with broader objectives of efficiency and compliance in government contracting.
    Similar Opportunities
    6505--Metformin SA Tablets REPACK PROGRAM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Metformin SA Tablets through its Repack Program, aimed at ensuring a stable supply of essential pharmaceuticals for veteran healthcare. Bidders are required to adhere to strict FDA good manufacturing practices, propose pricing that includes a 0.5% Cost Recovery Fee, and comply with the Drug Supply Chain Security Act regulations, among other requirements. This procurement is critical for maintaining the availability and quality of medications for veterans, reflecting the government's commitment to their healthcare needs. Interested contractors must submit their offers by January 21, 2025, at 2:30 PM CST, and can direct inquiries to Senior Contract Specialist Teresa Hussain at teresa.hussain@va.gov.
    6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Tamsulosin Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--761-25-1-015-0001 -Chelmsford CMOP Pharm -(VA-25-00012051)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quotation (RFQ) for various pharmaceutical products to be supplied to the Chelmsford VA Center facility. The procurement includes items such as a vaginal gel, multivitamin tablets, and a wound therapy solution, with specific quantities and packaging requirements outlined for each product. This solicitation underscores the VA's commitment to ensuring a stable supply of essential medications for veterans while adhering to federal procurement regulations. Interested vendors must submit their quotations by January 17, 2025, and provide necessary documentation, including a state wholesale distributor license and OEM authorization, to the designated contract specialist, Lacie Nowak, at Lacie.nowak@va.gov.
    6505--Carbidopa/Levodopa SA Tablet
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) 36E79725R0008 for the procurement of Carbidopa/Levodopa sustained release (SA) tablets, aimed at ensuring a continuous supply of these medications for various federal health services, including the Department of Defense and the Bureau of Prisons. The contract will be awarded for an initial period of one year, with the option to extend for four additional one-year periods, requiring offerors to provide unique branding and packaging without overlapping labels. The estimated annual usage totals approximately 119,875 bottles across two dosage forms, highlighting the importance of these medications in treating Parkinson's disease and related conditions. Interested parties should note that the electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026; questions can be directed to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov.
    6505--Baclofen Tablets (VA-25-00026620)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Baclofen tablets through its Pharmaceutical Prime Vendor Program, with the solicitation titled "6505--Baclofen Tablets (VA-25-00026620)." The primary objective of this procurement is to establish a reliable source for various strengths of Baclofen tablets, ensuring consistent availability and quality at pre-negotiated prices, while also requiring compliance with the Drug Supply Chain Security Act and Good Manufacturing Practices as evaluated by the FDA. This contract is crucial for maintaining the supply of necessary pharmaceuticals across VA facilities, addressing issues related to compliance, backorders, and recalls. Interested offerors must submit their bids, including pricing for the base year and four one-year options, along with a 0.5% Cost Recovery Fee, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to supply Cyclobenzaprine HCL Tablets under solicitation number VA-25-00015093. The procurement involves providing pharmaceutical supplies over a base year and four option years, with specific requirements for submission formats, safety protocols, and compliance with drug supply chain security standards. Cyclobenzaprine is a critical medication used for muscle relaxation, making this procurement essential for ensuring consistent availability for veterans and healthcare facilities. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details regarding the submission process and compliance requirements.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Nadolol Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Nadolol tablets as part of its Pharmaceutical Prime Vendor Program. This solicitation requires bidders to provide various dosages of Nadolol, along with unique National Drug Codes (NDCs), and to adhere to strict compliance with federal manufacturing practices and regulations, including the Drug Supply Chain Security Act. The consistent supply of these pharmaceuticals is crucial for meeting the healthcare needs of veterans, ensuring they receive necessary medications without interruption. Interested parties should contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further details, and must adhere to the submission requirements outlined in the solicitation document, which includes a 0.5% cost recovery fee and specific timelines for bid submission.
    6515--Pharmacy Management System ScriptPro Brand name or Equal
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of a ScriptPro Pharmacy Management System or an equivalent solution, as outlined in the combined synopsis/solicitation RFQ 36C26225Q0148. This procurement aims to enhance pharmacy management capabilities across various Veterans Integrated Service Network (VISN) 22 medical facilities and clinics, ensuring high-quality healthcare service delivery through reliable technological advancements. Interested vendors are encouraged to participate, particularly small businesses, including those owned by veterans and women, with bids due by February 4, 2025, at 7:00 AM PST. For inquiries, potential bidders should contact Contracting Officer Anthony Dela Cruz at anthony.delacruz@va.gov or by phone at 562-766-2284.